IMAC Holdings, Inc. (NASDAQ:BACK – Get Free Report) major shareholder Jorge Ruiz bought 164,872 shares of IMAC stock in a transaction dated Friday, March 22nd. The stock was purchased at an average cost of $3.58 per share, for a total transaction of $590,241.76. Following the purchase, the insider now owns 164,872 shares of the company’s stock, valued at approximately $590,241.76. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
IMAC Price Performance
Shares of BACK opened at $0.57 on Friday. IMAC Holdings, Inc. has a twelve month low of $0.47 and a twelve month high of $7.75. The company’s fifty day simple moving average is $0.82 and its 200-day simple moving average is $1.09.
IMAC (NASDAQ:BACK – Get Free Report) last announced its earnings results on Friday, January 17th. The company reported ($1.33) earnings per share for the quarter.
IMAC Company Profile
IMAC Holdings, Inc owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.
Featured Stories
- Five stocks we like better than IMAC
- Canada Bond Market Holiday: How to Invest and Trade
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Investors Need to Know About Upcoming IPOs
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Stocks to Consider Buying in October
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.